Investor777 (08/22/2009)

I would like to discuss several stocks with great potentials. Please note, the risk/reward comments here are relative to the other stocks. And they will change when time/price change.

1. 3 kingkong (high risk high reward)
FNM/FRE/AIG – pulled back with long uptail, be cautious, still have huge upside momentum

2. 1 grey horse (huge risk high reward)
CTIC – has risen 3280% from the annual low 2009, in retracement, seems ready to launch again. Please track the reaction to the news below next week:

NEW YORK (AP) -- Cell Therapeutics, Inc. said Friday it received $28.2 million from a sale of stock to a single investor.
The Seattle-based company said the investor bought Series 2 Preferred Stock shares, which were then converted to 18.9 million shares of common stock.
The investor also received warrants to buy up to 4.7 million additional shares of common stock at an exercise price of $1.70 per warrant share. The warrants, which could generate $8 million in proceeds for the company, will expire in nine months.

3. 2 king gamblers (mid risk mid reward)
LVS/MGM – reach resistance again, will rise again after consolidation. I called LVS/MGM Monday on DQ after the big pullback on 08/14/2009. And I urged all people who emailed me to buy when LVS was close to 12/MGM close to 8 Tuesday (08/18/2009). I even sent plan out to people to buy LVS near 11$, should panic drop happen (of course it did not happen). Many friends bought LVS (or bought it again) near 12$ last week, congratulations!

Sorry, I can not send you QQH one by one, for those who did not provide email in their QQH.

Below is automated translation in Chinese, which may not be accurate, FYI only.

Happy trading!


我想讨论几个有潜力的股票。
请注意，风险/回报的评论在这里是相对于其他股票。他们将改变，随时间/价格的变化。
1。 3 大金刚（高风险高回报）
FNM / FRE/ AIG 冲高回落，仍有巨大的上扬势头， 在周5大盘创2009新高时带长上影收盘，需当心。

2。 1匹灰马 （巨大的风险高回报）
CTIC 已从2009年的 最低上升3280％, 冲高回落，似乎准备再次发射。请跟踪下面消息 (ZT)：公司申请扩大淋巴瘤药Zin的适应症；Opaxio(聚谷氨酸紫杉醇)目前正在欧洲接受审评，申请作为一线疗法用于治疗非小细胞肺癌；递交Pixantrone用于非何杰金氏淋巴瘤的上市申请，希望年末获批。非何杰金氏淋巴瘤美国每年有近10万病例。而Opaxio的市场更大，目前紫杉醇的市场为20多亿美元。两只新药是否被批准，年底揭晓。目前距离年底有一段时间，有充足的时间适应市场炒作。公司另有1个新药处于PHASE II。

3。 2位赌神（中风险中回报）
LVS/MGM-再次达到阻力，调整后将再次上升。

我 再次在2009年8月14日周一之后的大回落后于DQ推荐LVS/MGM。我给所有给我发电子邮件的朋友说(抱歉，我不能给所有未提供email的朋友一一回信)，购买LVS接近12$/ MGM接近8$ 星期二（2009年8月18日）。我甚至发出推荐操作计划：购买11美元附近的LVS，如果出现恐慌下降（当然这没有发生）。上周许多朋友买了LVS近12美元（或再次买了），祝贺！

再次抱歉，我不能给所有未提供 email的朋友一一回悄悄话。

上面是自动翻译的中文，这可能不准确，仅供参考


祝大家过得愉快！